Open-Label Safety Study of AXS-05 in Subjects With Alzheimer's Disease Agitation
Conditions: Agitation in Patients With Dementia of the Alzheimer's Type; Alzheimer Disease; Agitation, Psychomotor Intervention: Drug: AXS-05 (dextromethorphan-bupropion) Sponsor: Axsome Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials